The impact of obesity on the outcomes of complex decongestive therapy among patients with breast cancer-related lymphedema.

IF 1.1 4区 医学 Q3 REHABILITATION
Aysegul Yaman, Pınar Borman, Funda Koç
{"title":"The impact of obesity on the outcomes of complex decongestive therapy among patients with breast cancer-related lymphedema.","authors":"Aysegul Yaman, Pınar Borman, Funda Koç","doi":"10.5606/tftrd.2025.15576","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to evaluate the influence of complex decongestive therapy (CDT) on patients with breast cancer-related lymphedema (BCRL) in terms of reducing volume, improving functional capabilities, and enhancing the quality of life and analyze the effect of obesity on their recovery process.</p><p><strong>Patients and methods: </strong>This retrospective study was conducted between January 2018 and March 2020. The investigation comprised individuals with unilateral BCRL who received CDT during the previous year. The participants were split into two classifications: those with a normal or overweight status (Group 1) and those classified as obese or morbidly obese (Group 2). Each participant engaged in CDT sessions five times weekly for three weeks. The groups were compared regarding their functional status and quality of life scores as measured by the Quick Disabilities of the Arm, Shoulder, and Hand and Lymphedema Quality of Life (LYMQOL)-Arm questionnaires.</p><p><strong>Results: </strong>This study included 81 female patients (mean age: 53.6±10.4 years; range, 28 to 87 years) with BCRL. Half of the participants were identified as obese and the mean body mass index (BMI) was 30.32±4.63 kg/m<sup>2</sup> . The median lymphedema duration was 12 months. After treatment, there was a notable reduction in both the mean initial limb volume and excess volumes (3183±681 cm<sup>3</sup> <i>vs.</i> 2912±599 cm<sup>3</sup> and 30.1% <i>vs.</i> 19.3%, respectively; p<0.001). Both groups showed substantial and similar enhancements in volumes, functional scores, and all subscores of the LYMQOL-Arm questionnaire following CDT. When the patients with a BMI below and above 30 were compared, the improvement in function and appearance scores of LYMQOL-Arm was substantially distinct between the two categories. We also indicated a substantial negative relationship between the enhancement of LYMQOL-Arm function and appearance subscores and BMI (p=0.005, r=-0.486 and p=0.042, r=-0.361).</p><p><strong>Conclusion: </strong>The influence of CDT on decreasing volume and improving functionality was comparable between obese and nonobese patients with BCRL; however, obesity may negatively impact CDT outcomes concerning quality of life issues.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":"71 1","pages":"48-55"},"PeriodicalIF":1.1000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12012919/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Physical Medicine and Rehabilitation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5606/tftrd.2025.15576","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"REHABILITATION","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aims to evaluate the influence of complex decongestive therapy (CDT) on patients with breast cancer-related lymphedema (BCRL) in terms of reducing volume, improving functional capabilities, and enhancing the quality of life and analyze the effect of obesity on their recovery process.

Patients and methods: This retrospective study was conducted between January 2018 and March 2020. The investigation comprised individuals with unilateral BCRL who received CDT during the previous year. The participants were split into two classifications: those with a normal or overweight status (Group 1) and those classified as obese or morbidly obese (Group 2). Each participant engaged in CDT sessions five times weekly for three weeks. The groups were compared regarding their functional status and quality of life scores as measured by the Quick Disabilities of the Arm, Shoulder, and Hand and Lymphedema Quality of Life (LYMQOL)-Arm questionnaires.

Results: This study included 81 female patients (mean age: 53.6±10.4 years; range, 28 to 87 years) with BCRL. Half of the participants were identified as obese and the mean body mass index (BMI) was 30.32±4.63 kg/m2 . The median lymphedema duration was 12 months. After treatment, there was a notable reduction in both the mean initial limb volume and excess volumes (3183±681 cm3 vs. 2912±599 cm3 and 30.1% vs. 19.3%, respectively; p<0.001). Both groups showed substantial and similar enhancements in volumes, functional scores, and all subscores of the LYMQOL-Arm questionnaire following CDT. When the patients with a BMI below and above 30 were compared, the improvement in function and appearance scores of LYMQOL-Arm was substantially distinct between the two categories. We also indicated a substantial negative relationship between the enhancement of LYMQOL-Arm function and appearance subscores and BMI (p=0.005, r=-0.486 and p=0.042, r=-0.361).

Conclusion: The influence of CDT on decreasing volume and improving functionality was comparable between obese and nonobese patients with BCRL; however, obesity may negatively impact CDT outcomes concerning quality of life issues.

肥胖对乳腺癌相关淋巴水肿患者综合减充血治疗结果的影响
目的:本研究旨在评价综合减充血疗法(CDT)对乳腺癌相关性淋巴水肿(BCRL)患者在体积缩小、功能改善、生活质量等方面的影响,并分析肥胖对其康复过程的影响。患者和方法:本回顾性研究于2018年1月至2020年3月进行。调查对象包括在前一年接受过CDT的单侧BCRL患者。参与者被分成两组:正常或超重的人(第一组)和肥胖或病态肥胖的人(第二组)。每位参与者每周参加五次CDT课程,为期三周。通过手臂、肩膀和手的快速残疾和淋巴水肿生活质量(lyqol)-手臂问卷调查,比较各组的功能状态和生活质量得分。结果:纳入81例女性患者,平均年龄53.6±10.4岁;(28至87年)。一半的参与者被确定为肥胖,平均体重指数(BMI)为30.32±4.63 kg/m2。中位淋巴水肿持续时间为12个月。治疗后,平均初始肢体体积和多余肢体体积分别减少了3183±681 cm3和2912±599 cm3,分别减少了30.1%和19.3%;结论:CDT对肥胖和非肥胖BCRL患者体积减小和功能改善的影响具有可比性;然而,肥胖可能会对CDT结果产生负面影响,涉及生活质量问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Turkish Journal of Physical Medicine and Rehabilitation
Turkish Journal of Physical Medicine and Rehabilitation Health Professions-Physical Therapy, Sports Therapy and Rehabilitation
CiteScore
2.20
自引率
0.00%
发文量
0
期刊介绍: The Turkish Journal of Physical Medicine and Rehabilitation (Formerly published as Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi) is the official journal of the Turkish Society of Physical Medicine and Rehabilitation. The journal is an international open-access, double-blind peer-reviewed periodical journal bringing the latest developments in all aspects of physical medicine and rehabilitation, and related fields. The journal publishes original articles, review articles, editorials, case reports (limited), letters to the editors. The target readership includes academic members, specialists, residents working in the fields of Physical Medicine and Rehabilitation. The language of the journal is English and it is published quarterly (in March, June, September, and December).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信